Author: "Emig M" / Database: Journals@OVID - Searchworks@Jio Institute Digital Library Search Results

Searchworks

Select search scope, currently: Articles

Catalog

books, media & more in Jio Institute collections

Articles

journal articles & other e-resources

Your search keyword '"Emig M"' showing total 9 results

Start Over Author "Emig M" Database Journals@OVID

9 results on '"Emig M"'

1. Quality-of-life and performance status results from the phase III RAINBOW study of ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated gastric or gastroesophageal junction adenocarcinoma†

Author: Al-Batran, S.-E., Van Cutsem, E., Oh, S. C., Bodoky, G., Shimada, Y., Hironaka, S., Sugimoto, N., Lipatov, O. N., Kim, T.-Y., Cunningham, D., Rougier, P., Muro, K., Liepa, A. M., Chandrawansa, K., Emig, M., Ohtsu, A., and Wilke, H.
Published: 2016
Full Text: View/download PDF

2. The c-kit (CD117) sequence variation M541L, but not N564K, is frequent in the general population, and is not associated with CML in Caucasians

Author: Krüger, S, Emig, M, Lohse, P, Ehninger, G, Hochhaus, A, and Schackert, H K
Published: 2006

3. The c-kit (CD117) sequence variation M541L, but not N564K, is frequent in the general population, and is not associated with CML in Caucasians

Author: Krüger, S, Emig, M, Lohse, P, Ehninger, G, Hochhaus, A, and Schackert, H K
Published: 2006

4. Impact of Chemoradiotherapy-Induced Anemia on Survival in Uniformly Staged Patients with Locally Advanced Squamous Cell Carcinoma of the Esophagus

Author: Hofheinz, R.-D., Raab, B., Mai, S., Wenz, F., Willeke, F., Emig, M., Buchheidt, D., Hehlmann, R., and Hochhaus, A.
Published: 2004
Full Text: View/download PDF

5. Clinical prognostic factors in uniformly staged and treated locally advanced squamous cell carcinoma of the esophagus: P768

Author: Raab, B., Hofheinz, R.-D., Emig, M., Wenz, F., Hehlmann, R., and Hochhaus, A.
Published: 2003

6. Molecular monitoring in CML patients during therapy with Imatinib (Glivec®): Low levels of residual disease are associated with continuous complete cytogenetic remission: P642

Author: Paschka, P., Müller, M. C., Merx, K., Kreil, S., Schoch, C., Lahaye, T., Petzold, A., Emig, M., Schwindel, U., Berger, U., Gschaidmeier, H., Hehlmann, R., and Hochhaus, A.
Published: 2003

7. Evaluation of haematopoetic recovery after autologous blood stem cell transplantation by soluble transferrin receptor: 346

Author: Metzgeroth, G., Bergmann, J., Schlegel, F., Emig, M., Maywald, O., Eichler, H., Hehlmann, R., and Hastka, J.
Published: 2002

8. A phase I study of high-dose 5-fluorouracil, sodium folinic acid, and mitomycin c in combination with escalating doses of Caelyx® in patients with pretreated gastrointestinal cancer: 166

Author: Hofheinz, R. D., Weisser, A., Willer, A., Worst, P., Emig, M., Hehlmann, R., and Hochhaus, A.
Published: 2002

9. MOLECULAR HETEROGENEITY IN COMPLETE CYTOGENETIC RESPONDERS ON INTERFERON-alpha THERAPY OF CML: LEVELS OF MINIMAL RESIDUAL DISEASE PREDICT RISK OF RELAPSE

Author: Hochhaus, A., Reichert, A., Saubele, S., Reiter, A., Emig, M., Hehlmann, R., Goldman, J. M., and Cross, N. C. P.
Published: 1998

Catalog

Books, media, physical & digital resources

See catalog results